ES2123269T5 - Receptores del factor 2 de liberacion de corticotropina. - Google Patents

Receptores del factor 2 de liberacion de corticotropina.

Info

Publication number
ES2123269T5
ES2123269T5 ES95925271T ES95925271T ES2123269T5 ES 2123269 T5 ES2123269 T5 ES 2123269T5 ES 95925271 T ES95925271 T ES 95925271T ES 95925271 T ES95925271 T ES 95925271T ES 2123269 T5 ES2123269 T5 ES 2123269T5
Authority
ES
Spain
Prior art keywords
receivers
release factor
corticotropine
receptors
corticotropine release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95925271T
Other languages
English (en)
Other versions
ES2123269T3 (es
Inventor
Derek Chalmers
Timothy W Lovenberg
Tilman Oltersdorf
Chen Wang Liaw
Dimitri E Grigoriadis
Souza Errol B De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neurocrine Biosciences Inc
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27401275&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2123269(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/381,433 external-priority patent/US5786203A/en
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Publication of ES2123269T3 publication Critical patent/ES2123269T3/es
Application granted granted Critical
Publication of ES2123269T5 publication Critical patent/ES2123269T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2228—Corticotropin releasing factor [CRF] (Urotensin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA MOLECULAS DE ACIDO NUCLEICO AISLADAS QUE CODIFICAN RECEPTORES CRF{SUB,2}, VECTORES DE EXPRESION RECOMBINANTES Y CELULAS HUESPED ADECUADAS PARA EXPRESAR TALES RECEPTORES, ASI COMO COMPOSICIONES Y METODOS QUE UTILIZAN TALES RECEPTORES.
ES95925271T 1994-06-14 1995-06-14 Receptores del factor 2 de liberacion de corticotropina. Expired - Lifetime ES2123269T5 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25995994A 1994-06-14 1994-06-14
US08/381,433 US5786203A (en) 1994-06-14 1995-01-31 Isolated nucleic acid encoding corticotropin-releasing factor2 receptors
US48598495A 1995-06-07 1995-06-07

Publications (2)

Publication Number Publication Date
ES2123269T3 ES2123269T3 (es) 1999-01-01
ES2123269T5 true ES2123269T5 (es) 2002-11-01

Family

ID=27401275

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95925271T Expired - Lifetime ES2123269T5 (es) 1994-06-14 1995-06-14 Receptores del factor 2 de liberacion de corticotropina.

Country Status (10)

Country Link
US (2) US6723841B2 (es)
EP (1) EP0724637B2 (es)
JP (1) JPH10501420A (es)
AT (1) ATE171212T1 (es)
AU (1) AU703140B2 (es)
CA (1) CA2193072A1 (es)
DE (1) DE69504808T3 (es)
DK (1) DK0724637T4 (es)
ES (1) ES2123269T5 (es)
WO (1) WO1995034651A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030232329A1 (en) * 1994-06-10 2003-12-18 Jeffrey R. De Wet Novel human crh receptor-related receptor
US6214797B1 (en) 1995-06-13 2001-04-10 The Salk Institute For Biological Studies Urocortin peptides, nucleic acid encoding same methods for using same
CA2223792A1 (en) * 1995-06-13 1997-01-03 The Salk Institute For Biological Studies Urocortin peptides
WO1997020928A1 (fr) 1995-12-06 1997-06-12 Sumitomo Pharmaceuticals Company, Limited Nouvelle semaphorine z et gene la codant
UA70912C2 (uk) * 1996-02-28 2004-11-15 Cінгента Партісіпейшнс Аг Молекула днк, яка кодує стійку до дії інгібітора рослинну протопорфіриногеноксидазу, спосіб одержання стійких до гербіциду рослин, спосіб боротьби з ростом небажаних рослин
US5888811A (en) * 1996-05-23 1999-03-30 Dupont Pharmaceuticals Company Corticotropin-releasing hormone receptor
AU7935098A (en) * 1997-06-30 1999-01-19 Taisho Pharmaceutical Co., Ltd. Proteins capable of binding to corticotropin-releasing factor
AU777469B2 (en) * 1999-04-15 2004-10-21 Cambridge University Technical Services Limited A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof
NZ516611A (en) * 1999-07-15 2003-09-26 Res Dev Foundation Mice that are homozygously deficient in CRFR2 and uses thereof in drug screening
US7674463B1 (en) * 1999-07-15 2010-03-09 Research Development Foundation Method of inhibiting angiogenesis by administration of a corticotropin releasing factor receptor 2 agonist
AU6514400A (en) * 1999-08-24 2001-03-19 Regents Of The University Of California, The Method of identifying urotensin ii receptor antagonists
AU2001280632A1 (en) * 2000-07-19 2002-01-30 Bristol-Myers Squibb Pharma Company CRF2 ligands in combination therapy
JP4830079B2 (ja) * 2000-11-29 2011-12-07 国立感染症研究所長 プロテアーゼ活性の測定方法
US6670140B2 (en) * 2001-03-06 2003-12-30 The Procter & Gamble Company Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
WO2005103690A2 (en) * 2004-04-24 2005-11-03 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with corticotropin releasing hormone receptor 2 (crhr2)
CA2749041C (en) * 2008-12-31 2019-09-03 Abbott Point Of Care Inc. Method and device for immunoassay using obligonucleotide conjugates
JOP20170153A1 (ar) 2016-07-15 2019-01-30 Lilly Co Eli نظائر urocortin-2 جديدة معدلة بحمض دهني لعلاج داء السكري وأمراض الكلى المزمنة

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030232329A1 (en) 1994-06-10 2003-12-18 Jeffrey R. De Wet Novel human crh receptor-related receptor
US5786203A (en) 1994-06-14 1998-07-28 Neurocrine Biosciences, Inc. Isolated nucleic acid encoding corticotropin-releasing factor2 receptors

Also Published As

Publication number Publication date
US6723841B2 (en) 2004-04-20
WO1995034651A3 (en) 1996-03-14
DK0724637T3 (da) 1999-06-14
DE69504808T2 (de) 1999-05-12
US7034118B2 (en) 2006-04-25
DE69504808T3 (de) 2002-12-12
US20020077468A1 (en) 2002-06-20
ES2123269T3 (es) 1999-01-01
AU703140B2 (en) 1999-03-18
EP0724637A1 (en) 1996-08-07
EP0724637B2 (en) 2002-06-05
AU2945595A (en) 1996-01-05
DK0724637T4 (da) 2002-09-16
DE69504808D1 (de) 1998-10-22
CA2193072A1 (en) 1995-12-21
ATE171212T1 (de) 1998-10-15
EP0724637B1 (en) 1998-09-16
JPH10501420A (ja) 1998-02-10
US20040185533A1 (en) 2004-09-23
WO1995034651A2 (en) 1995-12-21

Similar Documents

Publication Publication Date Title
ES2123269T5 (es) Receptores del factor 2 de liberacion de corticotropina.
MX2022006365A (es) Receptores de antigeno quimerico cd19 y cd22 y usos de los mismos.
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
EP0653940A4 (en) GLIALMITOGENIC FACTORS, THEIR PRODUCTION AND USE.
BG103091A (en) Shortened soluble receptors of type i & ii of the tumour necrotizing factor
ES2192561T3 (es) Adn que codifica el receptor ip de prostaglandina.
DE3477813D1 (en) Improved steel wire with high tensile strength
BR9914777A (pt) Moléculas isoladas de ácido nucléico que codificam os fatores induzìveis por células t (tifs), as proteìnas codificadas e os usos das mesmas
WO1996034107A3 (en) Antiviral proteins, dna coding sequences therefor, and uses thereof
BR0013101A (pt) Mistura dinamicamente vulcanizada, processo para prepapar elastÈmeros termoplásticos, elastÈmeros termoplásticos, e, uso de misturas
ES2191011T3 (es) Acido nucleico, vector de expresion y composiciones para la identificacion y sintesis de sialiltransferasas recombinantes.
ES8500218A1 (es) Un procedimiento para preparar peptidos sinteticos del tipo de las calcitoninas.
ES2120052T3 (es) Receptor de prostaglandina fp y dna que lo codifica.
ES2056763T1 (es) Producto para la fijacion del cabello que contiene lignina o un derivado de lignina y dihidroxipropil-lignina.
MX9403899A (es) Adn que codifica al receptor ep1 de prostaglandina
FR2744730B1 (fr) Nouvelle famille de canaux potassium de mammifere, leur clonage et leur utilisation notamment pour le criblage de drogues
FI971276A (fi) Lerk-6:ksi nimetty sytokiini
DE69619808T2 (de) Chimäre msp und daf proteine mit einem telloberflächenlokalisierendem domän
DE3372565D1 (en) Insecticidal compositions
ES2122291T3 (es) Receptor ep3 de la prostaglandina y adn que lo codifica.
ES2175246T3 (es) Reticulante pobre en reversion.
EP0643719A4 (en) NUCLEIC ACID SEQUENCES ENCODING NUCLEIC ACID SEQUENCES ENCODING THE INTERLEUKIN-9 RECEPTOR, OR COMPLEMENTARY TO THESE SEQUENCES.
ZA978503B (en) Vertebrate smoothened proteins
EA200000365A1 (ru) Полиморфные модификации дофетилида
EP0860501A3 (en) Corticotropin-releasing factor2 receptors

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 724637

Country of ref document: ES